How Long Can You Live With Cervical Myelopathy?

Cervical myelopathy does not carry a fixed expiration date, but it does shorten life on average. A large study tracking 349 patients over more than two decades found that death rates were about 18% higher than expected for people of the same age and sex without the condition, with average survival around 15 years from diagnosis. The more important finding, though, was that timely surgical treatment appeared to close that gap. What ultimately determines how long you live with cervical myelopathy has less to do with the diagnosis itself and more to do with how severe it gets before it is treated, how your body responds, and whether complications pile up along the way.

What the Mortality Numbers Actually Show

The clearest data on life expectancy comes from a study that followed patients with degenerative cervical myelopathy (DCM) for up to 25 years. Of 349 patients, about 39% died during follow-up. When researchers compared these deaths to what would be expected in age- and sex-matched people without the condition, they found a standardized mortality ratio of 1.18, meaning the DCM group had an 18% higher chance of dying during the study period.¹ That is a real increase, but it is nowhere near the dramatic reduction people sometimes fear when they hear “spinal cord compression.” For context, the average survival in that cohort was 15.3 years, with some patients living more than 24 years after treatment.

Two factors stood out as predictors of worse survival: older age at the time of surgery and severe disease. Among patients who survived at least two years after their operation, severe myelopathy was the only factor that remained independently associated with reduced survival, roughly 60% higher risk of death compared to those with milder disease.¹ The implication is straightforward: getting treated before the disease becomes severe makes a meaningful difference not just for function, but for longevity.

How the Disease Progresses If Left Alone

Cervical myelopathy is not one of those conditions that quietly stays put. The general pattern is a stepwise neurological decline, with stretches of relative stability interrupted by sudden drops in function.² You might go months or even years feeling about the same, and then notice your hands getting clumsier or your legs feeling heavier seemingly overnight. This staircase pattern makes it psychologically easy to put off treatment during the stable phases, which is part of why many people arrive at surgery with more advanced disease than necessary.

A meta-analysis that synthesized data into neurologic stability curves put some numbers on this trajectory. For people with mild myelopathy who did not have surgery, about 75% remained neurologically stable at five years and roughly 65% at 15 to 20 years. For those starting with moderate or severe disease, the picture was grimmer: only about 55% were stable at five years, and that dropped to around 43% at 15 to 20 years.³ In other words, if you start with moderate or severe symptoms, there is better than a coin-flip chance that you will keep getting worse over the long run without intervention.

What drives the damage is sustained compression of the spinal cord. The narrowing of the spinal canal, whether from disc bulging, bone spurs, or ligament thickening, does not just squeeze the cord mechanically. It triggers a cascade of injury involving reduced blood flow, toxic overstimulation of nerve cells, and programmed cell death, a process researchers have compared to what happens in traumatic spinal cord injuries, just in slow motion.⁴ Once cord tissue is lost this way, recovery becomes harder, which is why the timing of intervention matters so much.

When Does Surgery Make a Difference

Surgery is the standard treatment for moderate and severe cervical myelopathy, and the evidence strongly favors it over waiting. A systematic review of nonoperative management found that for moderate to severe disease, conservative treatment produced worse outcomes than surgery, even when the surgical patients started off in worse shape.⁵ The one exception was mild myelopathy, where limited evidence suggested that nonsurgical approaches could perform about as well as surgery in the short term.

For mild cases managed without surgery, the risk is not zero. One study following 56 patients treated conservatively found that about 20% deteriorated, and the strongest predictor of decline was circumferential spinal cord compression, meaning the cord was squeezed from all directions. Among patients with that pattern on imaging, nearly a third got worse.⁶ So even in mild disease, imaging findings can help identify who is more likely to need surgery sooner rather than later.

When surgery is performed, the functional gains are substantial and durable. A meta-analysis of operative outcomes showed large improvements in function at every time point measured, from 6 months out to beyond 3 years, with sustained benefits in disability and pain scores as well.⁷ Recovery is not always complete, but for most patients, surgery stops the decline and claws back a meaningful amount of lost function.

What Predicts a Good Recovery

Severity at the time of surgery is the single most consistent predictor of outcome. This is measured most commonly with the modified Japanese Orthopaedic Association (mJOA) score, a scale that rates hand dexterity, walking ability, and sensation. Patients with mild or moderate disease before surgery tend to recover a larger proportion of their lost function than those who arrive with severe deficits. Studies have confirmed that the mJOA score tracks well with objective measures like the amount of spinal cord compression seen on imaging.⁸

MRI findings also carry real prognostic weight. When the spinal cord shows a bright signal on T2-weighted imaging, that typically reflects swelling, inflammation, or damage within the cord itself. A study of 68 patients with this signal change found that those whose MRI signal improved after surgery recovered about 70% of their lost function, while those whose signal did not improve recovered only about 50%.⁹ This tells surgeons something useful: if the cord damage is still mostly reversible (the signal can clear after decompression), outcomes are better. If the damage is fixed, recovery is more limited.

Researchers are beginning to push this further with advanced imaging and machine learning. One group combined diffusion-based MRI measurements with clinical data and achieved nearly 90% accuracy in predicting which patients would improve after surgery, far better than using clinical data alone.¹⁰ This kind of tool is still in the research phase, but it points toward a future where prognosis is more personalized.

The Added Risk of Surgery for Older Adults

Because cervical myelopathy is primarily a degenerative condition, it overwhelmingly affects older adults, many of whom carry additional health burdens. Surgery is generally safe, but age does raise the stakes. An analysis of nearly 1,800 cervical spine surgery patients aged 65 and older found that about 10% experienced at least one complication or died in the perioperative period. Patients 75 and older faced roughly 70% higher odds of complications than younger elderly patients. Being dependent on others for daily activities or having significant medical comorbidities further raised the risk.¹¹

For patients 80 and older, the numbers are sobering but still show that most survive. One study of this age group found mortality rates of about 2% at 30 days, 9% at 6 months, and 13% at 2 years. The overall morbidity rate was close to 50%, and about 17% had major complications.¹² These figures can sound alarming in isolation, but they need to be weighed against the alternative: progressive loss of the ability to walk, use your hands, and control basic bodily functions. For a reasonably healthy 80-year-old with worsening myelopathy, surgery may still be the better bet, but that is a conversation that hinges on the individual’s overall health and goals.

How Diabetes and Other Health Conditions Affect Outcomes

Diabetes is one of the most common conditions that overlaps with cervical myelopathy, and its role is more nuanced than you might expect. One cross-sectional study found no significant differences in preoperative quality of life between myelopathy patients with and without diabetes or obesity.¹³ In other words, having diabetes does not necessarily mean you start out feeling worse. But the story changes after surgery. Research on diabetic patients undergoing cervical surgery found that blood sugar control before the operation made a clear difference in how well the spinal cord signal abnormalities resolved afterward. Keeping hemoglobin A1c below about 6.8% before surgery was associated with better neurological recovery.¹⁴

The practical takeaway is that if you have diabetes and are heading toward surgery for myelopathy, tightening your blood sugar control beforehand is one of the few modifiable factors that can improve your outcome. It will not change the mechanical compression, but it appears to help the cord heal once the pressure is relieved.

Quality of Life Can Be Hit Harder Than Life Expectancy

When people ask how long they can live with cervical myelopathy, the question they are often really asking is how well they can live. And the quality-of-life data is striking. A study comparing health survey scores of myelopathy patients against population norms and other chronic diseases found that cervical myelopathy caused worse physical disability than most conditions, with only heart failure scoring lower. For mental health, only back pain and sciatica caused greater impairment.¹⁵ Younger patients tended to show a larger gap between their function and age-matched norms, which makes sense: a 45-year-old who cannot button a shirt or walks with a shuffle is further from baseline than a 75-year-old with similar symptoms.

The indirect effects of myelopathy compound the problem. Reduced mobility increases the risk of falls, blood clots, deconditioning, and social isolation. Loss of hand dexterity can make it impossible to work, prepare food, or manage personal hygiene. These cascading disabilities are part of what drives the excess mortality seen in the data, not the spinal cord compression itself, but the downstream consequences of living with a body that does not work the way it used to.

Rehabilitation After Surgery

Surgery removes the mechanical compression, but getting back to functional independence often requires structured rehabilitation. Physical therapy programs after cervical spine surgery typically focus on balance, gait training, and gradually restoring strength. Case reports have documented meaningful gains with targeted rehabilitation, including improvements in walking distance, balance scores, and the ability to stand from a seated position.¹⁶

Recovery timelines vary widely. Some patients notice improvement in their hands and legs within weeks of surgery. Others continue making gradual gains for a year or more. The general pattern is that the fastest improvements happen in the first three to six months, with a slower trajectory after that. Patients who had symptoms for a shorter period before surgery tend to recover more completely, which circles back to the recurring theme: earlier treatment generally means better results.

What Happens to the Spine After Surgery

One concern that does not get enough attention in initial conversations about surgery is what happens to the spinal segments above and below the fusion site over time. When vertebrae are fused together, the adjacent levels take on extra mechanical stress, which can accelerate wear at those levels. This is called adjacent segment disease (ASD), and it is not rare. A meta-analysis found that about 28% of patients showed radiographic signs of ASD after cervical surgery, though only about 13% became symptomatic and roughly 6% needed a second operation.¹⁷ The yearly increase in new cases was modest but steady, about 1.4% per year for symptomatic ASD.

Disc replacement (arthroplasty) rather than fusion has been explored as a way to reduce this problem. A meta-analysis comparing the two approaches found that fusion patients had higher rates of adjacent segment degeneration, symptoms, and reoperation than disc replacement patients.¹⁸ Not every patient is a candidate for disc replacement, and the long-term data is still maturing, but it is worth discussing with your surgeon if you are young and likely to live many decades with a surgically treated spine.

Getting the Diagnosis Right

One underappreciated factor in outcomes is whether the diagnosis is correct in the first place. Cervical myelopathy shares symptoms with several other conditions, and misdiagnosis can lead to inappropriate surgery or dangerous delays. The most consequential mimic is amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that also causes progressive weakness and stiffness. Research has found that nearly half of ALS patients are initially misdiagnosed with cervical spondylosis. In a series of 63 patients with ALS, 30 also had cervical spondylotic changes on imaging, and six underwent spinal surgery shortly after their ALS diagnosis, with questionable benefit as their motor function continued to worsen from the underlying neurodegeneration.¹⁹ The overlap happens because both conditions can cause weakness, spasticity, and abnormal reflexes, and because many older adults have degenerative changes in their cervical spine that show up on MRI regardless of whether those changes are causing symptoms.

Other conditions that can look like myelopathy include multiple sclerosis, vitamin B12 deficiency, and normal pressure hydrocephalus. If your symptoms do not fit the expected pattern, if upper motor neuron signs are unusually widespread, or if there is muscle wasting without pain, pushing for a thorough neurological workup before agreeing to surgery is wise.

Disparities in Who Gets Diagnosed and Treated

How long you live with cervical myelopathy also depends, unfairly, on who you are and where you live. Research using large U.S. datasets has identified real disparities. Patients on Medicaid experienced longer delays before treatment (symptom duration over 12 months was significantly more common) and arrived at surgery with worse baseline disability and pain compared to privately insured patients.²⁰ African American patients also tended to present with worse disability scores at baseline. Lower socioeconomic status and lower educational attainment were both associated with worse starting scores across multiple measures of pain and function.

These disparities extend to what kind of surgery patients receive. Population-level data from the U.S. National Inpatient Sample showed that private insurance and white ethnicity were independent predictors of receiving certain surgical approaches and more extensive instrumented fusions. Survey data from people living with myelopathy also revealed that diagnostic delays were greater among Black or African American individuals.²¹ Since severity at the time of surgery is the strongest predictor of both functional recovery and long-term survival, these delays are not just inconveniences. They translate directly into worse outcomes for affected populations.